Skip to content

An evaluation test for alteration of the intestinal environment by probiotics consumption

An evaluation test for alteration of the intestinal environment by probiotics consumption - An evaluation test for alteration of the intestinal environment by probiotics consumption

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028733
Enrollment
36
Registered
2017-08-18
Start date
2017-08-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Consume one bottle of test food a day for 4 weeks - Washout 4 weeks - Consume one bottle of placebo food a day for 4 weeks Consume one bottle of placebo food a day for 4 weeks - Washout 4 weeks - Cons

Sponsors

CPCC Company Limited
Lead Sponsor
EZAKI GLICO CO., LTD.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy males and females aged 20 to 59 years old. (The ratio of men and women aim to be 1:2) (2) A half of female subjects aim to be the constipation tendency subjects who defecate 3 to 5 times in a week. (3) Subjects who do not regularly consume medicines, foods (which affect the intestinal environment) or supplements, during the examination period. (4) Subjects who show understanding of the study procedures and agreement with participating the study by written informed consent prior to the study.

Exclusion criteria

Exclusion criteria: (1) Subjects who didn't undergo abdominal surgical operation within 6 month before the test. (2) Subjects who didn't take antibiotics for 1 week or more within 6 month before the test. (3) Subjects who have allergy to test food. (4) Smokers (5) Subjects who are heavy drinkers of alcohol. (6) Subjects who are living together (consort or partner etc.) has planned to participate to the same clinical test. (7) Subjects who plan big change of lifestyle during the test. (8) Subjects with tendency of chronic diarrhea. (9) Subjects who considered unfitness for the test because of having previous and/or current medical history of serious disease of liver, kidney and heart. (10) Subjects who suspected chronic or serious infectious disease. (11) Females who are pregnant (including the possibility of pregnancy) or are lactating. (12) Subjects who have participated the other clinical test within 1 month before the test. (13) Subjects who have consumed medicines and/or foods which affect intestinal environment (yogurt, lactic acid bacteria beverage, oligo-sugar, dietary fiber) in the last 2 weeks before the day of preliminary examination. (14) Subjects who cannot refrain from consumption of medicines and foods which affect intestinal environment during the test. (15) Subjects who have been determined ineligible by principal investigator or sub-investigator.

Design outcomes

Primary

MeasureTime frame
16S rRNA gene-based metagenome analysis of gut microbiome and metabolome analysis of intestinal metabolites

Secondary

MeasureTime frame
* Defecation frequency * Property of stool * Volume of stool

Countries

Japan

Contacts

Public ContactMakoto Ichinohe

CPCC Company Limited Planning & Sales Department

cpcc-contact@cpcc.co.jp03-5297-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026